The following is selected financial information for D. Kay Dental Laboratories for 2020 and 2021: 2020 2021 Retained earnings, January 1 Net income Dividends declared and paid $57,000 41,000 46,000 19,000 74,000 22,000 Common stock Kay issued 2,400 shares of additional common stock in 2021 for $24,000. There were no other shareholder transactions. Required: Prepare a statement of shareholders' equity for D. Kay Dental Laboratories for the year ended December 31, 2021 D. Kay Dental Laboratories Statement of Shareholders' Equity For the Year Ended December 31, 2021 Total Shareholders Equity Common Stock Retained Earnings Balance at January 1, 2021 Balance at December 31, 2021